ArticleFuture microbiology2018
Development of rapid and simple experimental and in silico serotyping systems for Citrobacter.
Article in Future microbiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Whole-genome sequencing of clinical isolates of Citrobacter Europaeus in China carrying blaAnnals of clinical microbiology and antimicrobials · 2024Article
- Molecular analysis of clinicalFrontiers in microbiology · 2023Article
- A brief insight intoFrontiers in antibiotics · 2023Review
- Comparative genomic characterization of multidrug-resistant Citrobacter spp. strains in Fennec fox imported to China.Gut pathogens · 2021Article
- Genetic Analysis and Serological Detection of Novel O-Antigen Gene Clusters ofJournal of microbiology and biotechnology · 2021Article
- Genetic Characterization of the O-Antigen and Development of a Molecular Serotyping Scheme forFrontiers in microbiology · 2020Article
- Comparative Genomic Analysis ofFrontiers in microbiology · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
aimMembers of the genus Citrobacter are important opportunistic pathogens responsible for high mortality rate. Therefore, in this study, we aimed to develop efficient and accurate Citrobacter typing schemes for clinical detection and epidemiological surveillance. MATERIALS &
methodsUsing genomic and experimental analyses, we located the O-antigen biosynthesis gene clusters in Citrobacter genome for the first time, and used comparative genomic analyses to reveal the specific genes in different Citrobacter serotypes.
resultsBased on the specific genes in O-antigen biosynthesis gene clusters of Citrobacter, we established experimental and in silico serotyping systems for this bacterium.
conclusionBoth serotyping tools are reliable, and our observations are biologically and clinically relevant for understanding and managing Citrobacter infection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.